THC does pass into breast milk, and it does so readily. Because THC is fat-soluble, it accumulates in body fat and transfers efficiently into milk, which is itself a high-fat fluid. Pharmacokinetic modeling suggests that THC concentrations in breast milk actually exceed those in the mother’s blood, with a milk-to-plasma ratio of roughly 3.3. What remains far less clear is how much harm, if any, this exposure causes a nursing infant, and the gap between what we know about the transfer and what we know about the consequences is wide enough to make the topic genuinely unsettled.
Why THC Transfers So Easily Into Breast Milk
THC and other cannabinoids are lipophilic, meaning they dissolve in and cling to fat. After a mother inhales or ingests cannabis, THC enters the bloodstream, and because of its chemical properties, it is quickly taken up by fatty tissues throughout the body. The mammary gland is one of those fatty tissues, and the milk it produces is rich in lipids. This combination makes breast milk an efficient vehicle for cannabinoid transfer. A 2024 narrative review in Advances in Nutrition confirmed that cannabinoids are stored in adipose tissue, can easily reach the mammary gland, and are secreted into milk.1PubMed Central. Maternal Cannabis Use during Lactation and Potential Effects on Human Milk Composition and Production: A Narrative Review
THC isn’t the only cannabinoid that makes this journey. In a mouse study, researchers detected not only THC and CBD but also their primary breakdown products in breast milk samples from each corresponding treatment group.2BBA Advances. Cannabinoids accumulate in mouse breast milk and differentially regulate lipid composition and lipid signaling molecules involved in infant development While mouse physiology isn’t identical to human physiology, the finding underscores a broader point: the transfer isn’t limited to the parent compound. Metabolites tag along, which complicates any attempt to estimate total exposure.
How Much THC Actually Reaches the Infant
One of the most practical questions a breastfeeding mother has is: how large a dose is my baby actually getting? A 2023 pharmacokinetic modeling study tried to answer this. Researchers predicted that the relative infant dose, a standard measure of how much of a drug a nursing baby receives compared with the mother, ranged from about 0.3% to 0.9% for infants consuming THC-containing breast milk between birth and twelve months.3PubMed Central. Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach In pharmacology, a relative infant dose under 10% is typically considered the informal threshold below which most medications are thought to be compatible with breastfeeding. So by that yardstick, the dose looks small.
There are reasons to be cautious about treating that number as reassuring, though. The same modeling study found that when maternal cannabis smoking increased to about six sessions per day, the mother-to-infant plasma ratio jumped roughly three-fold.3PubMed Central. Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach So a mother who uses cannabis only occasionally delivers far less THC to her infant than one who uses it several times a day. Frequency and dose matter considerably, and the 0.3%–0.9% range reflects moderate use, not heavy use.
There’s also the issue of accumulation. Because THC stashes itself in fat, it doesn’t clear the body quickly. A single use can leave detectable THC in breast milk for days. That means there isn’t a straightforward “pump and dump” window the way there is with alcohol, which clears the milk roughly in step with the blood. Waiting a few hours after using cannabis does not reliably clear the milk of THC the way it does for a glass of wine.
What We Know (and Don’t Know) About Effects on the Baby
Here is where the evidence gets frustratingly thin. Despite decades of cannabis use among breastfeeding mothers, there are almost no well-designed studies that isolate the effects of THC in breast milk on infant health. A widely cited review noted bluntly that cannabinoid exposure through milk has not been shown to increase neonatal risk, but acknowledged that no appropriate studies of this question exist.4PubMed Central. Marijuana use and breastfeeding That wording is important: “has not been shown to” is not the same as “does not.” It means nobody has looked carefully enough to say either way.
The studies that do exist are tangled up in confounders. Mothers who use cannabis during breastfeeding are more likely to have used cannabis during pregnancy, which makes it nearly impossible to separate prenatal exposure from postnatal exposure through milk. Many also use tobacco or alcohol, live under higher stress, or have other factors that independently affect child development. Disentangling the specific contribution of THC in breast milk from all of this background noise would require the kind of randomized, controlled trial that no ethics board would approve. So researchers are left working with observational data, which can hint at associations but can’t prove causation.
What the observational data suggest, tentatively, is that the main areas of concern are neurodevelopmental. The developing infant brain has an active endocannabinoid system, and introducing external cannabinoids during a period of rapid brain growth raises theoretical concerns. But translating theoretical concerns into measured outcomes in human infants has proved elusive. No study has convincingly demonstrated that THC exposure through breast milk, at the doses typically delivered, causes cognitive or motor delays. That doesn’t mean it’s safe; it means the science hasn’t caught up to the question.
The Endocannabinoid System and Why It Matters for Newborns
One reason researchers worry about THC in breast milk is that the body already has its own version of cannabinoids, called endocannabinoids, and they play a surprisingly specific role in early life. Endocannabinoids have been detected in maternal milk, and they appear to be critical for a newborn’s ability to suckle. Research in mice has shown that activation of CB1 receptors, the same receptors that THC activates, is essential for the oral-motor coordination that allows newborns to latch and feed.5European Journal of Pharmacology. The endocannabinoid-CB(1) receptor system in pre- and postnatal life
This finding cuts in two directions. On one hand, it confirms that the endocannabinoid system is deeply involved in infant feeding, which suggests that flooding it with external THC could potentially disrupt normal signaling. On the other hand, it means the infant’s brain is already equipped to interact with cannabinoid-like molecules, and the low concentrations of THC in breast milk may not meaningfully outcompete the body’s own endocannabinoids. Research has even raised the possibility that disruptions to CB1 receptor signaling could contribute to failure-to-thrive in infants, the poorly understood condition in which babies fail to gain weight without an obvious medical cause.6PubMed. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood Whether THC in breast milk contributes to or protects against such problems remains unknown.
CB1 receptors also appear transiently in white-matter areas of the developing brain, suggesting a role in brain development beyond just feeding behavior.5European Journal of Pharmacology. The endocannabinoid-CB(1) receptor system in pre- and postnatal life This is the part that makes neuroscientists uneasy: if THC is activating receptors that are supposed to be fine-tuning brain wiring during a critical window, even low doses could theoretically matter. But “could theoretically matter” and “does measurably matter at these concentrations” are not the same claim, and the gap between them has not been bridged in humans.
Does Cannabis Change the Nutritional Quality of Breast Milk?
Beyond the question of THC itself reaching the baby, researchers have started asking whether cannabis use changes the overall composition of breast milk. The findings here are early and somewhat mixed. One study found that milk from cannabis users had slightly higher protein and about 11% lower fat than milk from non-users.7PubMed Central. The Effect of Cannabis Consumption During Lactation on the Macronutrient Concentrations in Breast Milk Fat is the primary energy source in breast milk, so a meaningful reduction would be worth paying attention to.
But other studies have reached different conclusions. A study that tracked macronutrient concentrations over twelve hours after cannabis use found no significant differences in lipid, protein, lactose, or fatty acid levels between cannabis users and controls at baseline or over time.8Current Developments in Nutrition. Acute Effect of Maternal Cannabis Use on Human Milk Composition A separate study similarly found no baseline macronutrient differences, though it did observe that lipid levels and certain fatty acids were lower in milk from cannabis users after use, and that lactose levels rose in controls but not in users over the study period.9PubMed. Short-Term Effects of Maternal Cannabis Use on Human Milk Macronutrient Composition: The Lactation and Cannabis (LAC) Study
An interesting wrinkle that appeared across studies is the correlation between THC concentration and milk fat. In milk from cannabis users, higher THC levels were associated with higher lipid content and lower lactose.8Current Developments in Nutrition. Acute Effect of Maternal Cannabis Use on Human Milk Composition This makes physical sense given that THC is fat-soluble and would tend to partition into the fattier fraction of milk, but it also raises the question of whether the drug is subtly reshaping the metabolic environment of the milk itself. It’s too early to say whether these shifts, if real and consistent, would affect infant growth or nutrition in any practical way.
What Medical Organizations Actually Say
Given how little definitive evidence exists, you might expect medical guidelines to be vague, and they are, but they lean in a clear direction. The American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Academy of Breastfeeding Medicine all discourage cannabis use during breastfeeding.10Neoreviews. High Stakes: Exploring the Impact of Cannabis Use in Pregnancy and Lactation But none of them say that a mother who uses cannabis should stop breastfeeding. That distinction matters.
A key AAP report spelled this out: an earlier policy statement that listed cannabis among substances “contraindicated” for breastfeeding mothers was widely misread as meaning breastfeeding itself was contraindicated if the mother used cannabis. The report clarified that this was not the intent. Instead, the recommendation is to encourage breastfeeding while strongly urging the mother to abstain from cannabis. The Academy of Breastfeeding Medicine echoed this position, stating that while abstaining from marijuana use is warranted, the data are not strong enough to recommend against breastfeeding entirely for a mother who does use it.11Pediatrics. Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes
The practical takeaway from these guidelines is that the benefits of breastfeeding are considered substantial enough that they likely outweigh the uncertain risks of low-level THC exposure through milk, at least for mothers who use cannabis occasionally rather than heavily. This is a risk-benefit calculation, not a clean safety endorsement. If you use cannabis and are breastfeeding, the official advice is to try to stop, but if you don’t stop, don’t switch to formula on that basis alone.
Why “Just Stop” Isn’t Always Simple
The guidance to abstain sounds straightforward, but the reality behind it is more complicated than it might appear. A survey of breastfeeding mothers who used cannabis found that only about half reported using it recreationally. The vast majority, roughly 89%, said they used cannabis for mental or physical health symptoms including anxiety, depression, chronic pain, gastrointestinal issues, and post-traumatic stress disorder.12PubMed. Mode of Cannabis Use and Factors Related to Frequency of Cannabis Use Among Breastfeeding Mothers: Results from an Online Survey For many of these women, cannabis is filling a gap left by the limited medication options considered safe during breastfeeding. Many conventional treatments for anxiety and depression carry their own unknown or concerning risk profiles in nursing mothers, and some women find cannabis more accessible or more effective for their symptoms.
This doesn’t make cannabis use during breastfeeding safe, but it does reframe the conversation. Telling a mother with debilitating postpartum anxiety to simply stop using the one thing that makes her functional isn’t helpful unless an alternative is on the table. Clinicians who work with breastfeeding mothers increasingly recognize that shaming or issuing blanket prohibitions can backfire: some mothers may stop breastfeeding rather than stop cannabis, and others may simply stop disclosing their use, which removes any chance of monitoring or harm reduction.
Healthcare provider advice does appear to make a difference in perception, though. A cross-sectional study using data from the Pregnancy Risk Assessment Monitoring System found that women who received advice about cannabis and breastfeeding were more likely to view cannabis use during breastfeeding as unsafe.13PubMed. Advice About Cannabis Use While Breastfeeding, Maternal Risk Perceptions, and Perinatal Cannabis Use: A Cross-Sectional Study of 2017-2021 PRAMS Data In other words, simply having the conversation in a clinical setting shifts how mothers weigh the risks. This suggests that open, non-judgmental communication from providers is one of the more effective tools available right now.
Pump and Dump Doesn’t Work for THC
One of the most common misconceptions about THC and breast milk is that you can treat it the way many mothers treat alcohol: pump and discard the milk produced shortly after use, then resume normal feeding. This strategy doesn’t work well for cannabis. Alcohol is water-soluble and clears breast milk in rough proportion to how it clears the blood, usually within a few hours of a single drink. THC, by contrast, is fat-soluble and accumulates in adipose tissue. It leaches back into the bloodstream and into milk over an extended period. Detectable THC has been found in breast milk for days after a single use, and in regular users, it may never fully clear between sessions.
This pharmacokinetic reality means there is no reliable safe window for breastfeeding after cannabis use. A mother who smokes cannabis once and then waits six hours before nursing has not meaningfully reduced the THC content of her milk the way she would have with a glass of wine. The lag between use and clearance is long enough, and variable enough between individuals, that timing strategies offer false reassurance. If you’re using cannabis and breastfeeding, the practical reality is that your baby is being exposed to some level of THC regardless of when you nurse relative to when you use.
Secondhand and Thirdhand Smoke Exposure
When discussing THC and breastfeeding, the conversation tends to focus narrowly on what gets into the milk. But if a mother smokes or vapes cannabis, the infant is also exposed to secondhand smoke or vapor, and this is a separate risk pathway that doesn’t depend on breastfeeding at all. Combusted cannabis smoke contains many of the same particulate pollutants and irritants found in tobacco smoke. Even vaporized cannabis releases fine particulate matter and volatile compounds.
Thirdhand exposure is another concern. Residues from cannabis smoke settle on surfaces, clothing, skin, and hair. An infant who is held against a mother’s chest shortly after she smoked is exposed through skin contact and inhalation of off-gassing residues, regardless of whether breastfeeding is involved. For mothers who use edibles or tinctures, this route of exposure is eliminated, though the THC-in-milk pathway remains. This is one reason some harm-reduction discussions have shifted toward advising mothers who will not stop using cannabis to at least switch to non-smoked forms and to use in a separate space from the infant.
The broader point is that THC in breast milk is only one piece of a larger exposure picture. A breastfeeding mother who smokes cannabis in the same room as her baby is delivering cannabinoids through the milk and exposing the infant to combustion byproducts through the air. Separating these two risks is important both for research and for practical decision-making, because a mother who switches to edibles eliminates the respiratory exposure while leaving the milk exposure intact.
Why the Research Gap Persists
It’s worth understanding why we know so little about this topic despite how common cannabis use during breastfeeding has become. The most fundamental barrier is ethical: you cannot randomize breastfeeding mothers into a cannabis group and a placebo group and then measure what happens to their babies. The studies that exist are observational, relying on mothers who self-report their use, and self-report in this context is notoriously unreliable. Many mothers underreport cannabis use to healthcare providers, especially in states or countries where it remains illegal. This means the “non-user” control groups in studies may include some users, diluting any differences between groups.
Sample sizes tend to be small, follow-up periods short, and outcome measures inconsistent across studies. Some measure motor development at six months; others measure cognitive scores at two years; still others look only at growth parameters. Without standardized endpoints and long follow-up, it’s nearly impossible to detect subtle developmental effects that might not manifest until a child is school-aged. Cannabis legalization has increased research interest and funding, but catching up on decades of data scarcity takes time. For now, the honest answer is that we know THC gets into milk efficiently, we know the dose is low by pharmacological standards, and we do not know with any confidence what that dose does to a developing infant over the long term.